Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2026-04-14 @ 1:24 PM
Study NCT ID:
NCT02419469
Status:
TERMINATED
Last Update Posted:
2018-06-11
First Post:
2015-04-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-11-13
Start Date Type:
ACTUAL
Primary Completion Date:
2017-06-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-06-22
Completion Date Type:
ACTUAL
First Submit Date:
2015-04-14
First Submit QC Date:
None
Study First Post Date:
2015-04-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-05-09
Results First Submit QC Date:
None
Results First Post Date:
2018-06-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-09
Last Update Post Date:
2018-06-11
Last Update Post Date Type:
ACTUAL